Towards Engineering Novel PE-Based Immunotoxins by Targeting Them to the Nucleus

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Exotoxin A (PE) from Pseudomonas aeruginosa is an ADP-ribosyltransferase that inhibits protein translation.
• PE is utilized in immunotoxins for targeted cancer therapy.
• Targeting cancer cells requires selective agents that differentiate from healthy cells.

Purpose of the Study:

• To engineer a novel PE mutein by incorporating a nuclear localization sequence (NLS) at its C-terminus.
• To evaluate the cytotoxic activity and biochemical properties of the NLS-PE mutein in cancer cell models.
• To investigate the mechanism of action and potential alternative functions of the modified toxin.

Main Methods:

• Recombinant expression and purification of PE and its muteins.
• Cytotoxicity assays using A549 and HepG2 cell lines.
• Biochemical characterization of the modified toxin's activity.

Main Results:

• A novel PE mutein with an NLS sequence was successfully designed and purified.
• The NLS-PE mutein exhibited significant cytotoxic activity in tested cancer cell lines.
• Furin cleavage was not essential for PE activity in these cell lines.
• Nuclear accumulation of PE led to increased toxicity, suggesting a novel mechanism possibly involving nuclease activity and DNA cleavage.

Conclusions:

• The NLS-PE mutein demonstrates enhanced selective toxicity against cancer cells.
• PE possesses a potential alternative intoxication mechanism involving nuclease activity and chromosomal DNA cleavage.
• Further research is needed to elucidate the molecular basis of this newly discovered nuclease activity.